We examined the time course of insulin-like growth factor binding protein (IGFBP) secretion and hormonal regulation of IGFBP and IGF-I secretion in porcine stromal vascular (S-V) cultures. Primary cultures of S-V cells derived from porcine adipose tissue were exposed to serum-free media with or without hormone treatment. Time course studies indicated that secretion of four IGFBP (IGFBP-1, -2, -3 and -4) by porcine S-V cells increased with time during the first 3 d after the switch to serum-free conditions and then decreased gradually. Growth hormone treatment stimulated secretion of each IGFBP by 47 ± 4.7, 46 ± 10.2, 70 ± 13.2, and 49 ± 5.6%, respectively, over control levels. The secretion of IGFBP-1, -2, -3, and -4 was enhanced by 91 ± 18, 80 ± 16, 74 ± 12, and 263 ± 48%, respectively, in T 4 -treated S-V cultures compared with untreated cultures. In contrast, dexamethasone reduced the abundance of the IGFBP by 28 to 50% of control levels. Insulin-like growth factor I secretion (844.63 ± 35.98 pg/mL) in vitro ( 3 d conditioned media) was increased ( P < .05) by GH (1,302.45 ± 12.95 pg/mL) and T 4 (1,291.60 ± 86.4 pg/mL) and decreased ( P < .05) by dexamethasone (552.5 ± 30.2 pg/mL) ( n = 4, S-V cell pools, P < .05). In addition to preadipocytes, other cells in S-V cultures also secrete IGFBP. In conclusion, the secretion of IGF-I and IGFBP by S-V cells is differentially regulated by hormones in vitro.
Introduction
Insulin-like growth factor I ( IGF-I) plays an important role in fetal and postnatal growth (Froesch et al., 1985; Steele and Elsasser, 1989) . Insulin-like growth factor I stimulates preadipocyte proliferation and differentiation in a dose-dependent manner in primary stromal-vascular ( S-V) and preadipocyte cell line cultures (Deslex et al., 1987; Ramsay et al., 1989; Wright and Hausman, 1995a) . In particular, IGF-I enhances the development of fat cell clusters in postconfluent porcine S-V cultures by increasing the number of cells per cluster, suggesting an autocrine/ paracrine function (Ramsay et al., 1989; Richardson et al., 1992; Wright and Hausman, 1995a) .
The IGF-I in biological fluids is invariably associated with specific high-affinity IGF-binding proteins ( IGFBP) (Vicki and Kerstin, 1990) , which modulate the biological activity and half-life of IGF-I (Clemmons et al., 1990) . Five IGFBP identified in porcine serum were modulated by endocrine and nutritional factors (McCusker et al., 1989) and were developmentally regulated (Lee et al., 1993) . The amount and type of IGFBP in muscle cell cultures dictated the myogenic response to IGF-I (McCusker and Clemmons, 1988; McCusker et al., 1991a) . Therefore, local production of IGFBP could have a major impact on the autocrine/paracrine mode of IGF-I action. Because the activity of locally produced IGF-I is probably controlled by IGFBP, the objective of this study was to determine the hormonal regulation of IGFBP and IGF-I secretion by porcine S-V cells in vitro.
Materials and Methods

Cell Preparation and Cell Culture
Pigs from 5 to 7 d of age were obtained from a commercial producer and overdosed with sodium thiopental and exsanguinated. All procedures for animal care were in accordance with protocols approved by the University of Georgia Institutional Animal Use and Care Committee. Subcutaneous adipose tissue was removed aseptically and digested with collagenase as described elsewhere (Hausman, 1989) . Aliquots of S-V cells were stained with Rappaport's and counted on a hemocytometer. Cells (S-V) were seeded in 35-mm tissue culture dishes containing 2 mL of seeding medium at a density of 10 4 /cm 2 . Seeding medium consisted of Dulbecco's modified Eagle's nutrient mixture F-12 Ham (Sigma Chemical, St. Louis, MO), 5 mM glucose, 40 mg/L of gentamicin sulfate, 50 mg/L of cephalothin, 2.5 mg/L of Amphotericin B (Gibco), and 10% fetal bovine serum ( FBS) . After 72 h of seeding in 10% FBS ( d 3), cultures were switched to serum-free medium with or without hormones (10 nM growth hormone [GH] , 10 nM dexamethasone [DEX] , or 50 nM thyroxine [T 4 ] ) (Hausman, 1989 . Serum-free medium was supplemented with an insulin-transferrin-sodium selenite ( ITS) supplement (insulin, 5 U/mL; transferrin, 5 mg/mL; and selenium, 5 ng/mL; Sigma Chemical). Media were changed every 3 d. To determine the ontogeny of IGFBP and IGF-I secretion in culture, conditioned media were collected 2 h and 1, 3, 6, and 9 d (in replicate cultures) after switching to serum-free media. Media were changed every 3 d, so media collected 3, 6, and 9 d after switching to serum-free media were conditioned for 3 d. Cultures used for the 2-h and 1-d media collections were removed from the study. Based on the results of these studies, conditioned media were routinely collected 3 d after switching to serum-free media for the hormone studies. Changes in IGFBP and IGF-I secretion during the first 3 d probably represent a direct hormonal influence that is not affected by adipocytes/preadipocytes induced by IGF-I because 6 d of exogenous IGF-I was necessary to induce adipogenesis in serum free S-V cultures. The 3-d treatment period was used in this study to examine the short-term response to hormones that may precede adipogenesis (Hausman, 1989; Chen et al., 1995a) . Furthermore, total cell number would not be influenced during 3 d of treatment because 6 d of treatment with these hormones (serum-free conditions) did not influence total cell number (Hausman, 1989; Hausman et al., 1992 ). Serum-free conditions limit cell proliferation; 6 d of IGF-I treatment per se without serum did not influence total cell number, whereas IGF-I with low levels of serum markedly increased cell number (Hausman, 1989; Chen et al., 1995a) .
Two approaches were used to determine the source of IGFBP secretion in S-V cultures. Adipocytes and preadipocytes were eliminated by treating S-V cultures with six anti-adipocyte monoclonal antibodies and rabbit complement for a period of 24 h from d 2 or 3 of culture (Wright and Hausman, 1995b) . The other approach involved maximally inducing preadipocyte differentiation by seeding S-V cells with 80 nM DEX in addition to DME/F12 plus 10% FBS.
Ligand Blotting
Conditioned media were concentrated using Ultrafree-Cl filters (Millipore, Bedford, MA) and mixed 4× Laemmli sample buffer (Laemmli, 1970) without 2-mercaptoethanol, boiled for 5 min, and loaded onto a 12.5% discontinuous SDS polyacrylamide gel. An equivalent amount of protein in approximately 100 mL of conditioned media was loaded onto each lane. The samples were electrophoresed at 35 mA for 4 h. Proteins were transferred to Immobilon-P membrane (Millipore) using a Trans-blot cell (BioRad, Hercules, CA). Electroblotting was performed according to the method of Hossenlopp et al. (1986) with some modifications. The blots were incubated with 100,000 cpm 125 I-labeled IGF-I/mL overnight at 4°C, rinsed, and then exposed at −80°C to Kodak X-OMAT film for 8 to 10 d. The IGFBP were visualized by autoradiography and molecular weights ( M r ) estimated by comparisons to prestained protein standards (Bio-Rad). Autoradiograms were quantified by computer laser densitometry (Molecular Dynamics, Sunnyvale, CA).
Immunoblot Analysis
Western blots were incubated with Tris-buffered saline ( TBS; 50 mM Tris and 200 mM NaCl, pH 7.4) containing 1% BSA and .05% Tween-20 for 1 h, followed by 2 h of incubation with 1:500 dilution of IGFBP-2 or -4 antibody (Upstate Biotechnology, Lake Placid, NY) in TBS plus 1% BSA. The blots were then incubated for 1 h with a 1:5,000 dilution of a goat antirabbit immunoglobulin G-alkaline phosphatase conjugate in TBS plus 1% BSA (McCusker et al., 1991b) . The blots were washed extensively and immunoreactive proteins identified using the Protoblot detection system (Promega, Madison, WI).
Measurement of Immunoreactive IGF-I in Conditioned Media
Conditioned media were collected 3 d after switching to serum-free media with or without hormone treatment and used for IGF-I RIA. Recombinant human IGF-I (Amgen Biologicals, Thousand Oaks, CA) was used as the standard. The [ 125 I]-IGF-I (Du Pont NEN Research Products, Boston, MA) had a specific radioactivity of 345 mCi/mg. Before IGF-I radioimmunoassay (RIA), conditioned media were acidified and subjected to C 18 Sep-Pak chromatography to remove IGFBP (Lee et al., 1991) . The IGF-I RIA was performed using rabbit IGF-I antiserum UBK 487 (distributed by the National Hormone and Pituitary Program, Bethesda, MD). The intra-and interassay variations were 5.4 and 6.6%, respectively. Six dishes per S-V cell pool were used for measurement. Total protein concentrations in conditioned media were determined by Bradford assay (Bio-Rad). 
Statistics
Data were subjected to ANOVA using SAS (1985) . Differences between means were determined by the least squares contrasts of the SAS procedure. Significant effects were defined at the 95% confidence level.
Results
Insulin Growth Factor Binding Protein Secretion
The time course of IGFBP secretion in porcine S-V cultures is shown in Figure 1 . Media conditioned for various times throughout the first 3 d of serum-free conditions (ITS) were collected for assay. Four binding proteins were identified by ligand blotting with estimated M r of 24, 29, 34, and 39 to 43 kDa that possibly represent IGFBP-4, BP-1, BP-2, and BP-3, respectively (Figure 1 ). The identity of IGFBP-2 and BP-4 were confirmed using immunoblot analysis: staining bands at 34 kDa and 24 kDa were identified, respectively . Because there are two isoforms of IGFBP-4 (30 kDa and 26 kDa; Coleman et al., 1991) , we cannot confirm the specificity of IGFBP-1 based on ligand blots, although the identity of IGFBP-1 in porcine serum has been confirmed using a specific IGFBP-1 antibody (McCusker et al., 1991b) . Four IGFBP were detected in conditioned media by 2 h after switching to serumfree media. There were apparent increases in the abundance of each form of IGFBP secreted during the first 3 d of serum-free conditions (Figure 1 ). Serumfree media conditioned for 3 d were collected at 6, 9, and 12 d of culture (Figure 1 ). Insulin-like growth factor binding protein concentrations were highest in media conditioned between d 3 and 6 of culture and were lowest in media conditioned between d 9 and 12 of culture (Figure 1 ). In the following experiments all media were collected 3 d after switching to ITS, with or without hormone treatment, and analyzed. The IGFBP secreted in cultures were differentially regulated by hormones (Figure 2 ). Quantitative analysis revealed that GH treatment stimulated each form of IGFBP secreted, especially IGFBP-3, which was increased by 70% over control levels ( n = 4, S-V cell pools, Figure 3) . The secretion of IGFBP-1, BP-2, BP-3, and BP-4 was enhanced by 91 ± 18, 80 ± 16, 74 ± 12, and 263 ± 48%, respectively, in T 4 -treated S-V cultures when compared to untreated cultures ( n = 4, S-V cell pools, Figure 4) . In contrast, DEX reduced the abundance of the IGFBP by 28 to 50% of control levels ( n = 3, S-V cell pools, Figure 5 ).
When examined at d 9 of culture, fat cell number was 6.5-fold greater in cultures treated with DEX for the first 3 d but there was no influence on total cell number compared to cultures without DEX. However, ligand blotting of conditioned media from these cultures showed that the concentration of the four IGFBP was not significantly changed despite the marked difference in fat cell number (Figure 6 ). Furthermore, monoclonal antibodies plus complement significantly reduced fat cell number in cultures by 95%, as reported elsewhere (Wright and Hausman, 1995b) . This was also not associated with changes in IGFBP secretion, because all IGFBP were detected in 
Insulin-like Growth Factor I Secretion
Insulin-like growth factor I secretion in porcine S-V cultures was also differentially regulated by GH, DEX, or T 4 . When treated with 10 nM GH or 50 nM T 4 for 3 d, IGF-I levels were increased in culture media (conditioned 3 d; n = 4, S-V cell pools, P < .05, Figure  7 ). However, DEX treatment markedly decreased IGF-I secretion ( n = 4, S-V cell pools, P < .05, Figure  7 ). Total protein concentration in conditioned media (95.87 ± 17.01 mg/mL) was increased by GH (171.78 ± 8.58 mg/mL), T 4 (159.80 ± 2.20 mg/mL), and DEX (157.37 ± 3.63 mg/mL) ( n = 4, S-V cell pools, P < .05).
Discussion
The use of serum-free cultures in the present study allowed investigation of IGFBP and IGF-I secretion without interference from residual IGFBP, IGF-I, and other hormones in serum. Therefore, in serum-free S-V cultures, IGFBP and IGF-I concentrations in the media reflected the release or production of these proteins by porcine preadipocytes. The current study demonstrated that porcine S-V cells produce or secrete four IGFBP in vitro. Time-course studies indicated that IGFBP secretion by porcine S-V cells gradually increased with the time during the first 3 d after switching to serum-free media (Figure 1) . Four IGFBP were detected in cultures only 2 h after switching to serum-free media. The IGFBP secretion by S-V cells reached a peak after 3 d of serum-free conditions and then decreased gradually. The secretion of IGF-I and total proteins also peaked after 3 d of serum-free media and declined thereafter (data not shown). One possible explanation is that protein synthesis per se decreases after a period of time in serum-free conditions.
The results herein clearly demonstrated that IGF-I and IGFBP secretion by porcine S-V cells in vitro is differentially regulated by hormones. For instance, GH treatment stimulated secretion of IGF-I and each IGFBP, especially BP-3. Growth hormone dependency of IGF-I and IGFBP-3 levels has also been demonstrated in various in vivo and in vitro studies (reviews, Vicki and Kerstin, 1990; Raffaele et al., 1994) . For example, expression and secretion of IGF-I and IGFBP-3 by cultured osteoblasts was dependent on GH (Schmid et al., 1992) . Growth hormone acutely regulated the abundance of multiple IGF-I transcripts in porcine S-V cultures (Gaskins et al., 1990b ) and increased the abundance of IGF-I mRNA and IGFBP-3 mRNA in porcine adipose tissue (Duffy et al., 1992) . However, in GH-treated porcine S-V cultures, increased IGF-I synthesis and secretion was associated with decreased preadipocyte development (Gaskins et al., 1990b) . This could be attributable to the effect of GH on IGFBP secretion in vitro because IGFBP-3 can block the acute insulin-like effect of IGF-I on lipogenesis and glucose oxidation in porcine adipose tissue (Walton et al., 1989) . In addition to IGFBP-3, the other IGFBP can modulate IGF-I responsiveness by changing IGF-I bioavailability and interaction with cell surface IGF-I receptors (Vicki and Kerstin, 1990) . Therefore, the adipogenic potential of locally produced IGF-I in GH-treated porcine S-V cultures may be blocked by IGFBP, especially BP-3.
In the present study, DEX treatment markedly reduced secretion of IGF-I and all four IGFBP in cultures. This effect seemed specific because total protein secretion was increased. Dexamethasone inhibited IGF-I mRNA in porcine S-V cells (Gaskins et al., 1990a) and glucocorticoids decreased IGF-I mRNA and IGFBP-3, -4, -5 expression and secretion in cultured osteoblasts (Ryo et al., 1994) . Glucocorticoids reduced proliferation and stimulated preadipocyte differentiation in preadipocyte cell lines and S-V cell cultures (review, Hausman et al., 1993) .
However, morphological studies indicated that DEX stimulates adipocyte development in a way distinct from IGF-I Wright and Hausman, 1995a) . For instance, DEX enhanced preadipocyte differentiation by enhancing preadipocyte recruitment and lipid filling in S-V cultures . In contrast, IGF-I stimulated preadipocyte development in porcine S-V cultures by increasing the replication of differentiated preadipocytes (Wright and Hausman, 1995a) . In vivo studies also demonstrated that treatment with hydrocortisone increased fat cell size in adipose tissue with no influence on apparent fat cell number and serum levels of IGF-I (Hausman and Wright, 1994) . Furthermore, DEX can inhibit expression of c-fos that may repress adipocyte-specific gene expression (Gaskins et al., 1990a) . Therefore, the decreased secretion of IGF-I and IGFBP induced by DEX may not be linked to enhancement of preadipocyte differentiation. Alternatively, DEX-induced decreases in IGFBP secretion could change the bioavailability of locally produced IGF-I, thereby mediating differentiation by antagonizing proliferation. For instance, DEXinduced decreased myoblast proliferation was paralleled by reduced secretion of IGFBP in vitro (McCusker and Clemmons, 1988) . Furthermore, in addition to regulation of IGFBP, DEX also modulates the components of an IGF-I signaling pathway (e.g., IGF-I receptor number) in rat myoblasts (Giorgino and Wang, 1993) . Therefore, glucocorticoid regulation of IGFBP secretion may play a role in the complex mechanism by which glucocorticoids modulate locally produced IGF-I action at receptor levels on target cells (Giorgino and Wang, 1993) .
Results of the present study also demonstrated that T 4 treatment markedly enhanced the secretion of IGF-I and four IGFBP, especially BP-4, which was increased by 163% over control values. Thyroid hormone also stimulates IGF-I and IGFBP-2 expression and secretion in rat osteoblast cultures (Schmid et al., 1992) . Thyroid status is associated with serum levels of IGF-I and IGFBP (Rodriguez-Arnao et al., 1993) . In hypothyroidism, serum levels of IGF-I and IGFBP-3 and IGF-I bioactivity were low (Miell et al., 1993) . In vivo studies demonstrated that T 4 treatment of hypophysectomized fetuses significantly increased levels of IGF-I and IGFBP in fetal pig serum and adipose tissue (Latimer et al., 1993; Chen et al., 1995b) . Although the specific biological function of each IGFBP in adipose tissue is not known, T 4 -induced increases in IGFBP, especially BP-4, may modulate the action of locally produced IGF-I and thereby mediate the effects of T 4 on adipose tissue development.
The present study also demonstrated that preadipocytes/adipocytes are neither the only nor the main source of IGFBP secretion since changes in fat cell number did not correlate with relative changes in IGFBP secretion. Previous studies in our lab demonstrated that IGF-I immunoreactivity was observed in morphologically differentiated cells and cells without lipid droplets, with no obvious relation to the functional status of any cell type (Gaskins et al., 1990b) . This suggests that IGF-I and IGFBP secreted by undifferentiated cells may play an important paracrine/autocrine role in adipose tissue development.
In summary, we demonstrated that porcine S-V cells are capable of producing IGF-I and four IGFBP. The secretion of IGF-I and IGFBP by S-V cells are differentially regulated by hormones in vitro. In addition to preadipocytes, other types of cells in S-V cultures also secrete IGFBP. The fact that porcine S-V cells secrete specific forms of IGFBP, and that endocrine factors influence the secretion of these IGFBP in a specific manner, suggests a paracrine/ autocrine function of IGFBP in IGF-I driven adipogenesis.
Implications
This investigation demonstrated that insulin-like growth factor-I (IGF-I) and insulin-like growth factor binding proteins (IGFBP) are secreted by porcine stromal-vascular cells and are differentially regulated by hormones in vitro. Although several lines of evidence have indicated IGF-I as a locally produced positive factor during adipose tissue development, IGFBP could have a major influence on the autocrine/ paracrine mode of IGF-I action on adipose tissues.
